{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:15:35Z","timestamp":1790727335044,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["[2019]5406"],"award-info":[{"award-number":["[2019]5406"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018555","name":"Science and Technology Program of Guizhou Province","doi-asserted-by":"publisher","award":["ZK(2021)012"],"award-info":[{"award-number":["ZK(2021)012"]}],"id":[{"id":"10.13039\/501100018555","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270848"],"award-info":[{"award-number":["32270848"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060564"],"award-info":[{"award-number":["82060564"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81871313"],"award-info":[{"award-number":["81871313"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.virol.2024.110171","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T08:44:17Z","timestamp":1720601057000},"page":"110171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Human umbilical cord mesenchymal stem cell exosomes deliver potent oncolytic reovirus to acute myeloid leukemia cells"],"prefix":"10.1016","volume":"598","author":[{"given":"Anqing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianyao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2024.110171_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.omto.2021.05.002","article-title":"Current strategies in engaging oncolytic viruses with antitumor immunity","volume":"22","author":"Boagni","year":"2021","journal-title":"Molecular therapy oncolytics"},{"issue":"8","key":"10.1016\/j.virol.2024.110171_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3390\/v10080421","article-title":"Going (Reo)Viral: Factors promoting successful reoviral oncolytic infection","volume":"10","author":"Bourhill","year":"2018","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.virol.2024.110171_bib3","doi-asserted-by":"crossref","first-page":"1703244","DOI":"10.1080\/20013078.2019.1703244","article-title":"Inhibiting extracellular vesicles formation and release: a review of EV inhibitors","author":"Catalano","year":"2019","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.virol.2024.110171_bib4","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/microorganisms12020274","article-title":"Extracellular vesicles: a novel mode of viral Propagation exploited by enveloped and non-enveloped viruses","volume":"12","author":"Chatterjee","year":"2024","journal-title":"Microorganisms"},{"issue":"22","key":"10.1016\/j.virol.2024.110171_bib5","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.3390\/molecules27227789","article-title":"Exosomes as novel delivery systems for application in Traditional Chinese Medicine","volume":"27","author":"Chen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.virol.2024.110171_bib6","first-page":"69","article-title":"Reovirus in cancer therapy: an evidence-based review","volume":"3","author":"Clements","year":"2014","journal-title":"Oncolytic Virotherapy"},{"issue":"5392","key":"10.1016\/j.virol.2024.110171_bib7","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.282.5392.1332","article-title":"Reovirus therapy of tumors with activated Ras pathway","volume":"282","author":"Coffey","year":"1998","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.virol.2024.110171_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41392-020-00261-0","article-title":"Exosomes: key players in cancer and potential therapeutic strategy","volume":"5","author":"Dai","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.virol.2024.110171_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.virol.2024.110171_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020558","article-title":"Potential of mesenchymal stromal cell-derived extracellular vesicles as natural Nanocarriers: Concise review","volume":"15","author":"Draguet","year":"2023","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.virol.2024.110171_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004464","article-title":"Preinduced reovirus-specific T-cell immunity enhances the anticancer efficacy of reovirus therapy","volume":"10","author":"Groeneveldt","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.virol.2024.110171_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172991","article-title":"Mesenchymal stem cells as carriers for systemic delivery of oncolytic viruses","volume":"874","author":"Hadry\u015b","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.virol.2024.110171_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/biores.2012.0205","article-title":"Reovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia","volume":"1","author":"Hall","year":"2012","journal-title":"BioResearch Open Access"},{"issue":"10","key":"10.1016\/j.virol.2024.110171_bib14","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.3390\/v12101086","article-title":"Intercellular transmission of naked viruses through extracellular vesicles: Focus on Polyomaviruses","volume":"12","author":"Helle","year":"2020","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.virol.2024.110171_bib15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/17425247.2019.1617269","article-title":"Achieving systemic delivery of oncolytic viruses","volume":"16","author":"Hill","year":"2019","journal-title":"Expet Opin. Drug Deliv."},{"issue":"7","key":"10.1016\/j.virol.2024.110171_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/v13071406","article-title":"Targeting JAK\/STAT signaling Antagonizes resistance to oncolytic reovirus therapy driven by prior infection with HTLV-1 in models of T-cell lymphoma","volume":"13","author":"Islam","year":"2021","journal-title":"Viruses"},{"issue":"16","key":"10.1016\/j.virol.2024.110171_bib17","doi-asserted-by":"crossref","first-page":"9060","DOI":"10.3390\/ijms22169060","article-title":"The role of exosome and the ESCRT pathway on enveloped virus infection","volume":"22","author":"Ju","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.virol.2024.110171_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s40257-020-00554-8","article-title":"An Update on the role of talimogene laherparepvec (T-VEC) in the treatment of melanoma: Best Practices and future directions","volume":"21","author":"Larocca","year":"2020","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.virol.2024.110171_bib19","article-title":"AAV-containing exosomes as a novel vector for improved gene delivery to lung cancer cells","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.virol.2024.110171_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11912-022-01341-w","article-title":"Oncolytic viruses and cancer Immunotherapy","volume":"25","author":"Malhotra","year":"2023","journal-title":"Curr. Oncol. Rep."},{"issue":"11","key":"10.1016\/j.virol.2024.110171_bib21","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.3390\/cancers12113219","article-title":"Past, present and future of oncolytic reovirus","volume":"12","author":"M\u00fcller","year":"2020","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.virol.2024.110171_bib22","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jhep.2013.07.010","article-title":"Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth","volume":"59","author":"Ong","year":"2013","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.virol.2024.110171_bib23","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1038\/leu.2015.88","article-title":"Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia","volume":"29","author":"Parrish","year":"2015","journal-title":"Leukemia"},{"key":"10.1016\/j.virol.2024.110171_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/OV.S143808","article-title":"Current understanding of reovirus oncolysis mechanisms","volume":"7","author":"Phillips","year":"2018","journal-title":"Oncolytic Virotherapy"},{"key":"10.1016\/j.virol.2024.110171_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.919819","article-title":"The role and therapeutic potential of macropinocytosis in cancer","volume":"13","author":"Qiu","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"5","key":"10.1016\/j.virol.2024.110171_bib26","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/mt.2015.44","article-title":"Mesenchymal stem cell-derived extracellular vesicles: toward cell-free therapeutic applications","volume":"23","author":"Rani","year":"2015","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.virol.2024.110171_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrclinonc.2018.15","article-title":"Immunotherapy: oncolytic viruses prime antitumour immunity","volume":"15","author":"Romero","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.virol.2024.110171_bib28","first-page":"47","article-title":"Cell carriers for oncolytic viruses: current challenges and future directions","volume":"2","author":"Roy","year":"2013","journal-title":"Oncolytic Virotherapy"},{"issue":"3386","key":"10.1016\/j.virol.2024.110171_bib29","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.130.3386.1387","article-title":"Reoviruses. A new group of respiratory and enteric viruses formerly classified as ECHO type 10 is described","volume":"130","author":"Sabin","year":"1959","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.virol.2024.110171_bib30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ymgme.2014.11.017","article-title":"Targeting novel signaling pathways for resistant acute myeloid leukemia","volume":"114","author":"Sakamoto","year":"2015","journal-title":"Mol. Genet. Metabol."},{"issue":"5","key":"10.1016\/j.virol.2024.110171_bib31","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1128\/JVI.78.5.2310-2318.2004","article-title":"Characterization of rotavirus cell entry","volume":"78","author":"S\u00e1nchez-San Mart\u00edn","year":"2004","journal-title":"J. Virol."},{"issue":"23","key":"10.1016\/j.virol.2024.110171_bib32","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1158\/1078-0432.CCR-14-1404","article-title":"A phase I trial of single-agent reolysin in patients with relapsed multiple myeloma","volume":"20","author":"Sborov","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virol.2024.110171_bib33","doi-asserted-by":"crossref","first-page":"9355","DOI":"10.2147\/IJN.S281890","article-title":"Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate","volume":"15","author":"Shao","year":"2020","journal-title":"Int. J. Nanomed."},{"issue":"16","key":"10.1016\/j.virol.2024.110171_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13164121","article-title":"Can the new and Old drugs exert an Immunomodulatory effect in acute myeloid leukemia?","volume":"13","author":"Tarantini","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.virol.2024.110171_bib35","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/978-1-59745-561-9_31","article-title":"Oncolytic viral therapy using reovirus","volume":"542","author":"Thirukkumaran","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.virol.2024.110171_bib36","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/acsnano.7b07782","article-title":"Protein profiling and sizing of extracellular vesicles from colorectal cancer patients via flow cytometry","volume":"12","author":"Tian","year":"2018","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.virol.2024.110171_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01734-17","article-title":"Exosomes mediate intercellular transmission of Porcine Reproductive and respiratory Syndrome virus","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"issue":"20","key":"10.1016\/j.virol.2024.110171_bib38","first-page":"10839","article-title":"The influence of oncolytic reovirus on the biological activities of umbilical cord-derived mesenchymal stem cells","volume":"24","author":"Wang","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.virol.2024.110171_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107437","article-title":"Mesenchymal stem cell carriers enhance antitumor efficacy induced by oncolytic reovirus in acute myeloid leukemia","volume":"94","author":"Wang","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"4","key":"10.1016\/j.virol.2024.110171_bib40","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3892\/ol.2021.12499","article-title":"Mesenchymal stem cell carriers enhance anti-tumor efficacy of oncolytic virotherapy","volume":"21","author":"Wang","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.virol.2024.110171_bib41","article-title":"Oncolytic viruses as a promising therapeutic strategy for hematological malignancies","volume":"139","author":"Yang","year":"2021","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.virol.2024.110171_bib42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.omto.2022.03.008","article-title":"Immunotherapy by mesenchymal stromal cell delivery of oncolytic viruses for treating metastatic tumors","volume":"25","author":"Yoon","year":"2022","journal-title":"Mol Ther Oncolytics"},{"issue":"7","key":"10.1016\/j.virol.2024.110171_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008668","article-title":"Marine medaka heat shock protein 90ab1 is a receptor for red-spotted grouper nervous necrosis virus and promotes virus internalization through clathrin-mediated endocytosis","volume":"16","author":"Zhang","year":"2020","journal-title":"PLoS Pathog."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224001922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682224001922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:23:15Z","timestamp":1759368195000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682224001922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":43,"alternative-id":["S0042682224001922"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2024.110171","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human umbilical cord mesenchymal stem cell exosomes deliver potent oncolytic reovirus to acute myeloid leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2024.110171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110171"}}